Stock CGON CG ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights CG Oncology, Inc.

Equities

CGON

US1569441009

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-14 pm EDT 		5-day change 1st Jan Change
27.31 USD +5.69% Intraday chart for CG Oncology, Inc. -19.56% 0.00%
May. 14 Goldman Sachs Upgrades CG Oncology to Buy From Neutral With $50 Price Target MT
May. 09 CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
CG Oncology, Inc. Announces Data from the Phase 3 BOND-003 Study Evaluating the Efficacy and Safety of Cretostimogene Monotherapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to Bacillus Calmette Guerin
CI
PACS Group to raise $450 mln in US IPO at over $3 bln valuation
RE
CG Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Moderna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debut
RE
Fractyl Health valued at $654.6 mln in tepid debut
RE
Fractyl Health prices US IPO below range to raise $110 mln
RE
Fractyl Health targets up to $762 mln valuation in US IPO
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CGON Stock
  4. News CG Oncology, Inc.
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW